US$ 20.31
glp 1 gip glucagon triple agonist Polyagonists Enable Increasingly Effective Treatment of Obesity and Diabetes | DZD Schematic illustration of monoagonists, dual
Description
How their strategy needs to change to capture the opportunity from or mitigate the risk of GLP-1RAs

Cardiac energy metabolism in heart failure

Avoid high-fat foods, sugary beverages, and full-fat dairy products such as milk, cheese, yogurt, and ice cream

Targeted medicines with few adverse effects may become a reality once these pathways are understood

23-25 Despite those studies showing an overall long-term benefit of tight sugar control in preventing worse retinopathy, a small percentage of subjects had a paradoxical early worsening seen in the first year
